"Receptors, Virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response.
Descriptor ID |
D011991
|
MeSH Number(s) |
D12.776.543.750.830
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Virus".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Virus".
This graph shows the total number of publications written about "Receptors, Virus" by people in this website by year, and whether "Receptors, Virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 1 | 1 | 2 |
1997 | 1 | 0 | 1 |
1998 | 2 | 2 | 4 |
1999 | 3 | 2 | 5 |
2000 | 3 | 2 | 5 |
2001 | 1 | 3 | 4 |
2002 | 2 | 9 | 11 |
2003 | 4 | 4 | 8 |
2004 | 1 | 4 | 5 |
2005 | 5 | 3 | 8 |
2006 | 1 | 4 | 5 |
2007 | 1 | 2 | 3 |
2008 | 2 | 1 | 3 |
2010 | 3 | 1 | 4 |
2011 | 1 | 1 | 2 |
2012 | 1 | 2 | 3 |
2013 | 1 | 0 | 1 |
2014 | 4 | 2 | 6 |
2015 | 1 | 2 | 3 |
2016 | 2 | 1 | 3 |
2017 | 0 | 1 | 1 |
2018 | 2 | 1 | 3 |
2019 | 1 | 0 | 1 |
2020 | 2 | 4 | 6 |
2021 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Virus" by people in Profiles.
-
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike. Nature. 2023 Dec; 624(7992):639-644.
-
Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking. Immunity. 2023 Oct 10; 56(10):2442-2455.e8.
-
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022 08; 608(7923):603-608.
-
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Proc Natl Acad Sci U S A. 2021 09 21; 118(38).
-
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein. Cell Rep. 2021 08 31; 36(9):109628.
-
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell. Cell Rep. 2021 07 13; 36(2):109364.
-
Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies. Structure. 2021 07 01; 29(7):655-663.e4.
-
The N-linked glycosylations of TIGIT Asn32 and Asn101 facilitate PVR/TIGIT interaction. Biochem Biophys Res Commun. 2021 07 12; 562:9-14.
-
Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein. Cell. 2020 12 10; 183(6):1536-1550.e17.
-
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains. Cell Host Microbe. 2020 12 09; 28(6):867-879.e5.